Page last updated: 2024-08-18

pyrazolanthrone and fullerene c60

pyrazolanthrone has been researched along with fullerene c60 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Funakoshi-Tago, M; Kasahara, T; Mashino, T; Nagata, T; Nakamura, S; Tago, K; Tanaka, K; Tsukada, M	1

Other Studies

1 other study(ies) available for pyrazolanthrone and fullerene c60

Article	Year
Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway. Cellular signalling, 2012, Volume: 24, Issue:11 Topics: Amino Acid Substitution; Animals; Anthracenes; Apoptosis; Cell Line; Cell Transformation, Neoplastic; Fullerenes; Janus Kinase 2; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; MAP Kinase Kinase 7; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Proto-Oncogene Proteins c-myc; RNA Interference; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1	2012

Article

Year

Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway.

Cellular signalling, 2012, Volume: 24, Issue:11

Topics: Amino Acid Substitution; Animals; Anthracenes; Apoptosis; Cell Line; Cell Transformation, Neoplastic; Fullerenes; Janus Kinase 2; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; MAP Kinase Kinase 7; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Proto-Oncogene Proteins c-myc; RNA Interference; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1

2012